This HTML5 document contains 115 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
n11http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q46809320
rdf:type
wikibase:Item
schema:description
научна статия 2005年學術文章 บทความทางวิทยาศาสตร์ 2005年學術文章 article scientific vitenskapelig artikkel tudományos cikk wetenschappelijk artikel επιστημονικό άρθρο 2005年学术文章 bài báo khoa học מאמר מדעי artykuł naukowy tieteellinen artikkeli article científic գիտական հոդված سائنسی مضمون 2005年學術文章 2005年学术文章 article scientifique (publié 2005) vedecký článok artikull shkencor 2005年学术文章 научни чланак articol științific 2005年の論文 2005年學術文章 mokslinis straipsnis bilimsel makale artigo científico (publicado na 2005) vetenskaplig artikel artigo científico artículo científico publicado en 2005 artículu científicu наукова стаття, опублікована в листопаді 2005 мақолаи илмӣ naučni članak 2005년 논문 2005年学术文章 научная статья مقالهٔ علمی 2005年學術文章 teaduslik artikkel 2005年學術文章 ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ videnskabelig artikel (udgivet 2005) vitskapeleg artikkel vědecký článek articolo scientifico мақолаи илмӣ 2005 nî lūn-bûn 2005年学术文章 научни чланак scientific article scienca artikolo wissenschaftlicher Artikel სამეცნიერო სტატია مقالة علمية artigo científico (publicado na 2005) artikulong pang-agham
p:P577
wds:Q46809320-15905743-2897-4A2F-B45F-E898FB97435B
wdt:P577
2005-11-01T00:00:00Z
p:P407
wds:Q46809320-0CDAAB52-0610-4837-AE83-F1E67DA87CC9
wdt:P407
wd:Q1860
p:P2093
wds:Q46809320-C5684F89-2C68-4723-8366-53BC47F02AE3 wds:Q46809320-9A4A750E-39F4-473A-A27B-9A83ED6D93E1 wds:Q46809320-8FB01E65-EF06-4E76-B1B4-2ACC859F0CDD wds:Q46809320-15187E7B-E055-462B-8BDF-19064D46517D wds:Q46809320-0E2C2A24-8FFD-4384-9DC9-B9F6087EC213 wds:Q46809320-2F696E9F-491B-485F-AE52-63C78ACBECC9 wds:Q46809320-376BB347-AE2C-423F-8DFD-116B53E121A3
wdt:P2093
Barbara Uscinska James Carmichael David A Cameron Mahesh Parmar Alison L Jones Wendi Qian Ruth E Langley
rdfs:label
Phase III trial of epirubicin plus paclitaxel compared with epirubicin plus cyclophosphamide as first-line chemotherapy for metastatic breast cancer: United Kingdom National Cancer Research Institute trial AB01. Phase III trial of epirubicin plus paclitaxel compared with epirubicin plus cyclophosphamide as first-line chemotherapy for metastatic breast cancer: United Kingdom National Cancer Research Institute trial AB01.
skos:prefLabel
Phase III trial of epirubicin plus paclitaxel compared with epirubicin plus cyclophosphamide as first-line chemotherapy for metastatic breast cancer: United Kingdom National Cancer Research Institute trial AB01. Phase III trial of epirubicin plus paclitaxel compared with epirubicin plus cyclophosphamide as first-line chemotherapy for metastatic breast cancer: United Kingdom National Cancer Research Institute trial AB01.
schema:name
Phase III trial of epirubicin plus paclitaxel compared with epirubicin plus cyclophosphamide as first-line chemotherapy for metastatic breast cancer: United Kingdom National Cancer Research Institute trial AB01. Phase III trial of epirubicin plus paclitaxel compared with epirubicin plus cyclophosphamide as first-line chemotherapy for metastatic breast cancer: United Kingdom National Cancer Research Institute trial AB01.
p:P50
wds:Q46809320-1486D9DF-F971-48EB-868E-0C8F53AB7347
wdt:P50
wd:Q37828919
p:P1476
wds:Q46809320-B2D9C952-1983-46D3-B238-DF3C763CF30E
wdt:P1476
Phase III trial of epirubicin plus paclitaxel compared with epirubicin plus cyclophosphamide as first-line chemotherapy for metastatic breast cancer: United Kingdom National Cancer Research Institute trial AB01.
p:P304
wds:Q46809320-A9311153-3A32-49B2-86E2-7DC85A6AB6B9
wdt:P304
8322-8330
p:P31
wds:Q46809320-CDC21151-4663-4125-B6C3-959059EFBB14
wdt:P31
wd:Q13442814
p:P921
wds:Q46809320-6636610E-472B-454F-A91A-36D681A7B2E8 wds:Q46809320-2C1307B3-EF5F-4EE7-855A-F0BC6516B363 wds:Q46809320-2D709856-20D1-4A7C-AA50-E7117506D530 wds:Q46809320-B4DB8673-13E5-48DD-A85B-7F970C223B86 wds:Q46809320-CABE1E18-A36B-425F-8385-889E22456FB1
wdt:P921
wd:Q145 wd:Q423762 wd:Q974135 wd:Q12859063 wd:Q42824827
p:P698
wds:Q46809320-521D358D-E5FE-486F-93DC-9A165E8FDCB7
wdtn:P698
n12:16293863
wdt:P698
16293863
p:P1433
wds:Q46809320-76144624-63E6-4A26-9398-70DCD9B4EECF
wdt:P1433
wd:Q400292
p:P433
wds:Q46809320-43E9352A-9BF9-4734-9CAA-EF07B77FB623
p:P478
wds:Q46809320-EAED55AB-D9CC-489B-8333-B5D40FE4028A
wdt:P433
33
wdt:P478
23
p:P356
wds:Q46809320-3D17DFFD-4E1F-4300-A91F-7CC071658D2E
wdtn:P356
n11:JCO.2005.01.1817
wdt:P356
10.1200/JCO.2005.01.1817